A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease.
McArthur JG, Svenstrup N, Chen C, Fricot A, Carvalho C, Nguyen J, Nguyen P, Parachikova A, Abdulla F, Vercellotti GM, Hermine O, Edwards D, Ribeil JA, Belcher JD, Maciel TT.
McArthur JG, et al. Among authors: svenstrup n.
Haematologica. 2020 Mar;105(3):623-631. doi: 10.3324/haematol.2018.213462. Epub 2019 May 30.
Haematologica. 2020.
PMID: 31147439
Free PMC article.